Literature DB >> 32592037

Gastrointestinal Stromal Tumor (GIST) in Long-Standing Crohn's Disease on Anti-TNF Therapy.

David Mendel1, Taseen Syed2,3, H Robert Lippman4, Brian Davis5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 32592037     DOI： 10.1007/s12029-020-00442-8

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  17 in total

1.  Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.

Authors:  Markku Miettinen; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2005-01       Impact factor: 6.394

2.  Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up.

Authors:  Markku Miettinen; Hala Makhlouf; Leslie H Sobin; Jerzy Lasota
Journal:  Am J Surg Pathol       Date:  2006-04       Impact factor: 6.394

3.  Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.

Authors:  Wim G Goettsch; Steffan D Bos; Nancy Breekveldt-Postma; Mariel Casparie; Ron M C Herings; Pancras C W Hogendoorn
Journal:  Eur J Cancer       Date:  2005-11-15       Impact factor: 9.162

Review 4.  Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.

Authors:  D A Katzka; E V Loftus; M Camilleri
Journal:  Clin Pharmacol Ther       Date:  2012-07-25       Impact factor: 6.875

Review 5.  Gastrointestinal stromal tumors: pathology and prognosis at different sites.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

Review 6.  Gastrointestinal stromal tumours: origin and molecular oncology.

Authors:  Christopher L Corless; Christine M Barnett; Michael C Heinrich
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

7.  DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.

Authors:  Marco Novelli; Sabrina Rossi; Manuel Rodriguez-Justo; Philippe Taniere; Beatrice Seddon; Luisa Toffolatti; Chiara Sartor; Pancras C W Hogendoorn; Raf Sciot; Martine Van Glabbeke; Jaap Verweij; Jean Yves Blay; Peter Hohenberger; Adrienne Flanagan; Angelo P Dei Tos
Journal:  Histopathology       Date:  2010-08       Impact factor: 5.087

8.  Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.

Authors:  Bengt Nilsson; Per Bümming; Jeanne M Meis-Kindblom; Anders Odén; Aydin Dortok; Bengt Gustavsson; Katarzyna Sablinska; Lars-Gunnar Kindblom
Journal:  Cancer       Date:  2005-02-15       Impact factor: 6.860

9.  Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site.

Authors:  T S Emory; L H Sobin; L Lukes; D H Lee; T J O'Leary
Journal:  Am J Surg Pathol       Date:  1999-01       Impact factor: 6.394

Review 10.  The experience of a referral centre and literature overview of GIST and carcinoid tumours in inflammatory bowel diseases.

Authors:  Gianluca Pellino; Rosa Marcellinaro; Giuseppe Candilio; G Serena De Fatico; Elia Guadagno; Severo Campione; Giuseppe Santangelo; Alfonso Reginelli; Guido Sciaudone; Gabriele Riegler; Silvestro Canonico; Francesco Selvaggi
Journal:  Int J Surg       Date:  2015-12-18       Impact factor: 6.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.